Page last updated: 2024-11-11

pentamorphone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID5464186
CHEMBL ID2107032
SCHEMBL ID120834
MeSH IDM0163428

Synonyms (30)

Synonym
pentamorphone
rx-77989
a-4492 ,
D05416
68616-83-1
pentamorphone (usan/inn)
rx77989
pentamorphona [inn-spanish]
mm4487b4mw ,
7,8-didehydro-4,5alpha-epoxy-3-hydroxy-17-methyl-14-(pentylamino)morphinan-6-one
unii-mm4487b4mw
morphinan-6-one, 7,8-didehydro-4,5-epoxy-3-hydroxy-17-methyl-14-(pentylamino)-, (5alpha)-
pentamorphona
pentamorphonum
pentamorphonum [inn-latin]
rx 77989
pentamorphone [usan:inn]
14b-n-pentylaminomorphinone
CHEMBL2107032
SCHEMBL120834
pentamorphone [inn]
morphinan-6-one, 7,8-didehydro-4,5-epoxy-3-hydroxy-17-methyl-14-(pentylamino)-, (5.alpha.)-
pentamorphone [usan]
pentamorphone [mart.]
(4r,4as,7ar,12br)-9-hydroxy-3-methyl-4a-(pentylamino)-2,3,4,4a-tetrahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinolin-7(7ah)-one
Q7165029
DTXSID901018235
pentamorphone; rx 77989;a 4492
penomorphone
(4r,4as,7ar,12br)-9-hydroxy-3-methyl-4a-(pentylamino)-2,4,7a,13-tetrahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one

Research Excerpts

Overview

Pentamorphone is a novel, potent opiate with rapid onset and short duration of action that has been reported to produce analgesia with limited depression of ventilation. It appears to be an analgesic with clinically tolerable side effects in the range 0.12 to 0.24 microgram.kg-1.

ExcerptReferenceRelevance
"Pentamorphone is a new, highly potent opioid reported to have minimal cardiovascular effects in humans and a high therapeutic index in animals. "( Pharmacodynamics of pentamorphone during coronary artery bypass grafting in humans.
Falinski, BA; Hug, CC; Klochany, A; Sebel, PS, 1992
)
2.05
"Pentamorphone is a novel, potent opiate with rapid onset and short duration of action that has been reported to produce analgesia with limited depression of ventilation. "( Depression of ventilatory responses to hypoxia and hypercapnia after pentamorphone.
Afifi, MS; Camporesi, EM; Cohen, NA; Glass, PS; Shook, JE, 1990
)
1.96
"Pentamorphone appears to be an analgesic with clinically tolerable side effects in the range 0.12 to 0.24 microgram.kg-1 that merits further evaluation under clinical conditions."( Evaluation of pentamorphone in humans: a new potent opiate.
Camporesi, EM; Glass, PS; Quill, T; Reves, JG; Shafron, D, 1989
)
1.36
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (25.00)18.7374
1990's6 (75.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.19

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.19 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index4.76 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.19)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials4 (50.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (50.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]